MODERN APPROACHES TO THE TREATMENT OF DIABETIC RETINOPATHY

Diabetic retinopathy (DR) remains one of the leading causes of preventable vision loss and blindness among working-age adults worldwide. This review highlights current concepts in the pathogenesis, classification, and, most importantly, modern evidence-based therapeutic strategies for managing diabetic retinopathy, including systemic risk factor control, laser photocoagulation, intravitreal anti-VEGF agents, corticosteroid therapy, and vitrectomy. The article also discusses emerging technologies such as sustained-release drug implants and gene therapy prospects. Emphasis is placed on the importance of timely screening, multidisciplinary collaboration, and patient education to improve outcomes and preserve vision.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-07-19
DOI
https://doi.org/10.5281/zenodo.16157541
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MODERN APPROACHES TO THE TREATMENT OF DIABETIC RETINOPATHY

Zenodo (CERN European Organization for Nuclear Research)
Retinal Diseases and Treatments
article

MODERN APPROACHES TO THE TREATMENT OF DIABETIC RETINOPATHY

article en

Abstract

Diabetic retinopathy (DR) remains one of the leading causes of preventable vision loss and blindness among working-age adults worldwide. This review highlights current concepts in the pathogenesis, classification, and, most importantly, modern evidence-based therapeutic strategies for managing diabetic retinopathy, including systemic risk factor control, laser photocoagulation, intravitreal anti-VEGF agents, corticosteroid therapy, and vitrectomy. The article also discusses emerging technologies such as sustained-release drug implants and gene therapy prospects. Emphasis is placed on the importance of timely screening, multidisciplinary collaboration, and patient education to improve outcomes and preserve vision.

Zenodo (CERN European Organization for Nuclear Research)
University of Central Asia (KG)
Openalex Percentile: Top 42%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.